This Stock Jumped 49% in One Month and 835% in a Year: Why Cupid Shares Are Rising

Cupid Limited has quietly turned into one of the biggest wealth creators in the Indian stock market.

The stock closed at ₹179.48 on June 24, 2026, after touching a fresh 52-week high of ₹182.88. It has gained approximately 49% in one month, 123% in three months and more than 835% over the past year.

These returns are adjusted for the company’s 4:1 bonus issue completed in March 2026. The bonus increased the number of shares held by investors and reduced the price per share proportionately, without creating additional wealth by itself.

So, what is driving the rally?

The answer goes beyond condoms and bonus shares. Cupid is reporting rapid earnings growth, expanding manufacturing capacity, building a domestic FMCG business and targeting a sharp increase in revenue over the next three years.

At the same time, its valuation has risen to levels where even a small disappointment could trigger volatility.

Cupid Share Price and Returns

The returns are based on adjusted market data available on June 24, 2026. Cupid’s closing price was ₹179.48, compared with its adjusted 52-week low of around ₹18.17.

Why Is Cupid Share Price Rising?

Cupid’s recent rise appears to be the result of several developments coming together: record financial performance, aggressive management guidance, promoter buying, capacity expansion and growing expectations from its FMCG business.

1. Cupid Delivered Its Best-Ever Financial Performance

The strongest reason behind the rally is the company’s rapid earnings growth.

Cupid reported revenue from operations of approximately ₹358 crore in FY26, an increase of nearly 95% over the previous year. Net profit rose by about 165% to ₹108 crore.

The March quarter was particularly strong:

The company did not simply grow revenue. It also expanded margins as higher volumes, a better product mix and operating leverage improved profitability.

This combination of strong sales growth and even faster profit growth is one of the main reasons investors have been willing to assign Cupid a higher valuation.

2. Management Has Set Aggressive FY27 Targets

Cupid has guided for another major jump in its financial performance.

Management is targeting revenue of ₹600 crore and net profit of ₹180 crore in FY27. This implies revenue growth of nearly 68% over FY26 while maintaining a net profit margin of around 30%.

The longer-term targets are even more ambitious:

If Cupid achieves these targets, revenue could more than triple between FY26 and FY29.

The stock market is forward-looking. Part of the current rally appears to reflect expectations that Cupid can successfully deliver this growth.

However, these are management targets, not guaranteed earnings. The higher the valuation becomes, the more important quarterly execution will be.

3. Promoter Buying Strengthened Investor Confidence

Promoter purchases have provided another positive signal.

Chairman and Managing Director Aditya Kumar Halwasiya acquired 26 lakh Cupid shares on June 2 and another 21 lakh shares on June 3 through open-market transactions.

After the June 3 purchase, his individual holding increased to approximately 33.29%, while the total promoter-group holding rose to around 46.24%.

Promoter buying is often interpreted positively because it suggests that those closest to the business remain confident about its prospects.

Still, promoter purchases should not be treated as a guarantee of future returns. Investors must evaluate the company’s earnings and valuation independently.

4. Manufacturing Capacity Is Being Expanded

Cupid is investing heavily to support its growth plans.

Its expanded manufacturing platform is designed to provide annual capacity of approximately:

• 1.25 billion male condoms
• 125 million female condoms
• Higher production of personal lubricants
• Nearly four lakh diagnostic kits per day by the end of 2026

The company acquired land in Palava, Maharashtra, for a new manufacturing facility. This expansion is expected to add approximately 770 million male condoms and 75 million female condoms to annual capacity.

This investment is important because Cupid cannot achieve its FY27-FY29 targets using its older production base alone.

Capacity creation, however, is only one part of the equation. The company must also generate enough demand, receive regulatory approvals and operate the new facilities at healthy utilisation levels.

5. Cupid Is Entering Premium Nitrile Female Condoms

Cupid has started developing nitrile female condoms, a premium category that can command prices around 25% to 35% higher than traditional products.

Historically, this market has had very limited global competition.

Cupid says it is the only Indian condom manufacturer with the ability to manufacture both latex and nitrile products. If the development and approval process succeeds, this could create a differentiated export opportunity.

Female condoms are already an important part of Cupid’s business. The new product could improve realisations and strengthen the company’s position in international institutional tenders.

But the opportunity remains under development. Investors should wait for regulatory approvals, commercial orders and revenue contribution before assigning it full value.

6. Cupid Is No Longer Only an Export Condom Company

One of the biggest changes in Cupid’s business is its expansion into domestic consumer products.

In FY26, its revenue mix was:

The FMCG segment now includes condoms, personal lubricants, deodorants, perfumes, petroleum jelly, hair oil, body oils and other wellness products.

Cupid says its products are available across more than 1.5 lakh retail outlets. Its modern-trade presence covers over 2,900 stores and is targeted to cross 4,000 stores in FY27.

This diversification reduces reliance on institutional condom orders. It also provides access to a much larger domestic consumer market.

The challenge will be building durable brands. Manufacturing a consumer product is easier than persuading customers to choose it repeatedly in a competitive retail market.

7. Baazar Style Investment Could Expand Distribution

Cupid has committed ₹331.53 crore to acquire convertible warrants in Baazar Style Retail, which could translate into an approximately 11.92% stake on a diluted basis.

The first payment of ₹82.88 crore has already been deployed.

Baazar Style operates more than 260 stores, primarily in value-focused consumer markets. The network is expected to expand to over 500 stores within the next two to three years.

Cupid expects this partnership to generate approximately ₹150 crore of incremental revenue in FY27, with annual potential reaching around ₹500 crore within three years.

The strategic logic is straightforward: Cupid gets access to a ready retail network, while Baazar Style can offer a wider range of personal-care and wellness products.

However, this is a large investment relative to Cupid’s current balance sheet. Investors should closely monitor the returns generated from the partnership and whether it distracts capital from the core manufacturing business.

8. Export Business Remains a Strong Foundation

Despite the domestic expansion, exports remain central to Cupid’s business.

Exports contributed approximately ₹208 crore, or 59% of FY26 revenue. The company has supplied products across more than 125 countries and holds WHO/UNFPA prequalification for both male and female condoms.

Such certifications are important because government agencies and international health organisations generally buy only from approved suppliers.

Cupid is also targeting deeper penetration in the Gulf region and additional international tenders. Management expects its global footprint to expand by approximately 35% over the coming year.

This export foundation gives Cupid a credible base while its domestic FMCG business develops.

9. Diagnostics Could Become Another Growth Engine

Cupid manufactures rapid diagnostic products for HIV, hepatitis, syphilis and pregnancy testing.

During FY26, the company received CE EU IVDR certification for its HIV 1 and 2 antibody and Hepatitis B test kits. It also received CE certification for syphilis and pregnancy test kits.

These approvals can help Cupid enter the European Economic Area and other markets that recognise CE certification.

The company plans to expand diagnostic-kit capacity from roughly 1.5 lakh kits per day to around four lakh kits per day by the end of 2026.

Diagnostics currently forms a relatively small portion of revenue, but successful international commercialisation could create a meaningful third growth engine alongside contraceptives and FMCG products.

Did the 4:1 Bonus Issue Cause the Rally?

The bonus issue helped increase the number of shares available for trading and made the adjusted per-share price appear more accessible to retail investors.

Cupid issued four new shares for every one share held, with March 9, 2026, as the record date.

However, bonus shares do not change a company’s underlying value. An investor holding one ₹500 share before a 4:1 bonus would theoretically hold five shares worth around ₹100 each after adjustment.

The rally after the bonus reflects increased demand and business expectations, not wealth created by the corporate action itself.

Can Cupid Shares Continue to Rise?

Cupid’s growth story has genuine strengths:

• FY26 revenue nearly doubled
• Net profit grew by approximately 165%
• Management has provided aggressive multi-year targets
• Promoters have increased their holding
• Manufacturing capacity is expanding
• The domestic FMCG network is growing
• Export certifications create entry barriers
• The company has a low-debt balance sheet

The concern is that much of this optimism may already be reflected in the share price.

At ₹179.48, Cupid was trading at a trailing price-to-earnings ratio above 220 and a price-to-book ratio above 50. Such valuations leave little room for slower growth, margin pressure or project delays.

Key Risks Investors Should Track

Expensive Valuation

The stock is valued for exceptional growth. Even a good quarter may disappoint if it falls short of very high expectations.

Aggressive Management Guidance

Reaching ₹600 crore revenue in FY27 requires a significant jump from FY26. Delays in production or distribution could affect this target.

Promoter Pledging

Approximately 24.79% of promoter holdings were pledged as of March 2026. Pledged shares can increase risk during a sharp decline in the stock price.

Capital Allocation Risk

The Baazar Style investment is sizeable. Its success will depend on how effectively the partnership generates sales and profits.

Export and Tender Dependence

International institutional orders can be large but irregular. Regulatory changes, currency movements or delayed tenders may affect revenue.

New Capacity Execution

New factories and production lines require capital, approvals, skilled employees and sufficient customer demand. Delays could reduce expected returns.

What Should Investors Watch Next?

The most important indicators are:

1. Progress towards the ₹600 crore FY27 revenue target
2. Net profit margin remaining near or above 30%
3. Utilisation of the expanded manufacturing capacity
4. Commercial orders for nitrile female condoms
5. Growth from the Baazar Style partnership
6. Revenue from the diagnostics business
7. Cash flow and working-capital movement
8. Changes in promoter pledging
9. Valuation compared with actual earnings growth

Final Takeaway

Cupid shares have gained approximately 49% in one month and more than 835% in one year because the company has transformed from a niche condom exporter into a broader sexual-wellness, FMCG and diagnostics business.

The FY26 performance supports part of the optimism. Revenue nearly doubled, profit grew 165%, capacity is being expanded and management has set ambitious growth targets through FY29.

But the valuation now demands near-perfect execution.

Cupid may continue to deliver strong business growth, yet that does not automatically mean the stock will repeat its past returns. From here, investors should focus less on how much the share has already risen and more on whether earnings can grow quickly enough to justify its valuation.

Frequently Asked Questions

Why is Cupid share price rising?

Cupid shares are rising because of record FY26 earnings, aggressive FY27 guidance, promoter buying, manufacturing expansion and growth in exports, FMCG and diagnostics.

How much return has Cupid delivered in one month?

Cupid gained approximately 49% during the one-month period ended June 24, 2026.

What is Cupid’s one-year return?

Adjusted market data shows a one-year return of approximately 835% as of June 24, 2026.

What are Cupid’s FY27 targets?

Management is targeting approximately ₹600 crore in revenue and ₹180 crore in net profit for FY27.

What does Cupid Limited manufacture?

Cupid manufactures male and female condoms, personal lubricants, diagnostic kits and domestic FMCG and personal-care products.

Is Cupid share overvalued?

Cupid’s business is growing quickly, but the stock trades at a very high earnings and book-value multiple. This creates significant valuation risk if growth slows.

Sources and Editorial Note

This article is based on Cupid Limited’s FY26 results presentation, stock-exchange filings, promoter disclosures and adjusted market-price data available on June 24, 2026. Returns may vary slightly between data providers and should be interpreted after adjusting for the March 2026 bonus issue.

Disclaimer

This article is for educational and informational purposes only. It is not investment advice or a recommendation to buy or sell Cupid Limited shares. Investors should conduct independent research or consult a SEBI-registered investment adviser.